EMBO Molecular Medicine appoints Philippe Sansonetti as new Chief Editor
Heidelberg, 1 February 2017 – EMBO is pleased to announce the appointment of microbiologist Philippe Sansonetti as new Chief Editor of EMBO Molecular Medicine. Dr Sansonetti, who is the Director of the Molecular Microbial Pathogenesis Laboratory at the Institut Pasteur in Paris, takes up the post with immediate effect.
Lithuania joins the EMBO Installation Grants scheme
Heidelberg, 23 January 2017 – EMBO welcomes Lithuania as a member of the EMBO Installation Grants scheme. Early-career scientists looking to move to Lithuania to establish their own, independent research group can apply to the scheme for financial support for their first three to five years.
Remembering where to get high
Heidelberg, 11 January 2017 - Addiction-related memories are exceptionally strong and stable, suggesting that addictive drugs remodel the brain’s circuitry in a prominent and lasting way. In the past decade, researchers have used mouse models to unravel how cellular changes in the nucleus accumbens (NAc), a brain structure involved in action selection associated with arousal and reward, may contribute to addiction-related behavior. Whereas neuronal remodeling in the NAc explains a wide range of addictive behaviors, it is not required for all of them, according to a study published today in The EMBO Journal.
Ottoline Leyser honoured with the 2017 FEBS | EMBO Women in Science Award
Heidelberg, 9 January 2017 – EMBO and FEBS announce plant biologist Ottoline Leyser as the recipient of the tenth FEBS | EMBO Women in Science Award.
T. + 49 160 9019 3839